000			02305 a2200565 4500
005			20250515215234.0
264		0	_c20100928
008			201009s 0 0 eng d
022			_a1600-0765
024	7		_a10.1111/j.1600-0765.2009.01256.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLuckprom, P
245	0	0	_aAdenosine triphosphate stimulates RANKL expression through P2Y1 receptor-cyclo-oxygenase-dependent pathway in human periodontal ligament cells. _h[electronic resource]
260			_bJournal of periodontal research _cJun 2010
300			_a404-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine Diphosphate _xanalogs & derivatives
650	0	4	_aAdenosine Triphosphate _xpharmacology
650	0	4	_aBiomechanical Phenomena
650	0	4	_aBone Remodeling _xphysiology
650	0	4	_aBone Resorption _xphysiopathology
650	0	4	_aCells, Cultured
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors
650	0	4	_aCyclooxygenase 2 _xdrug effects
650	0	4	_aCyclooxygenase 2 Inhibitors _xpharmacology
650	0	4	_aDinoprostone _xantagonists & inhibitors
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEstrenes _xpharmacology
650	0	4	_aHumans
650	0	4	_aIndomethacin _xpharmacology
650	0	4	_aIsoquinolines _xpharmacology
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aPeriodontal Ligament _xcytology
650	0	4	_aPhosphodiesterase Inhibitors _xpharmacology
650	0	4	_aPurinergic P2 Receptor Antagonists
650	0	4	_aPyrrolidines _xpharmacology
650	0	4	_aPyrrolidinones _xpharmacology
650	0	4	_aRANK Ligand _xantagonists & inhibitors
650	0	4	_aRNA, Small Interfering _xpharmacology
650	0	4	_aReceptors, Purinergic P2 _xdrug effects
650	0	4	_aReceptors, Purinergic P2Y1
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aThiocarbamates _xpharmacology
650	0	4	_aType C Phospholipases _xantagonists & inhibitors
700	1		_aWongkhantee, S
700	1		_aYongchaitrakul, T
700	1		_aPavasant, P
773	0		_tJournal of periodontal research _gvol. 45 _gno. 3 _gp. 404-11
856	4	0	_uhttps://doi.org/10.1111/j.1600-0765.2009.01256.x _zAvailable from publisher's website
999			_c19699304 _d19699304